Ligand Pharmaceuticals SG&A Expense (TTM) Analysis

Ligand Pharmaceuticals Inc (LGND)

97.37 -2.01 (-2.02%) USD | NASDAQ | Sep 27, 16:00

97.29 -0.08 (-0.08%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1994. Upgrade now.

Date	Value
June 30, 2024	59.22M
March 31, 2024	52.89M
December 31, 2023	52.79M
September 30, 2023	67.93M
June 30, 2023	68.19M
March 31, 2023	68.99M
December 31, 2022	70.06M
September 30, 2022	45.97M
June 30, 2022	43.77M
March 31, 2022	46.40M
December 31, 2021	47.09M
September 30, 2021	65.70M
June 30, 2021	68.01M
March 31, 2021	63.36M
December 31, 2020	60.01M
September 30, 2020	44.63M
June 30, 2020	39.14M
March 31, 2020	40.06M
December 31, 2019	41.88M
September 30, 2019	42.77M
June 30, 2019	42.88M
March 31, 2019	41.18M
December 31, 2018	37.73M
September 30, 2018	34.32M
June 30, 2018	31.72M

Date	Value
March 31, 2018	28.97M
December 31, 2017	28.65M
September 30, 2017	27.70M
June 30, 2017	27.22M
March 31, 2017	27.90M
December 31, 2016	27.65M
September 30, 2016	28.06M
June 30, 2016	26.48M
March 31, 2016	26.47M
December 31, 2015	25.40M
September 30, 2015	23.71M
June 30, 2015	25.48M
March 31, 2015	23.49M
December 31, 2014	22.57M
September 30, 2014	21.47M
June 30, 2014	19.49M
March 31, 2014	18.55M
December 31, 2013	17.98M
September 30, 2013	17.77M
June 30, 2013	17.32M
March 31, 2013	16.87M
December 31, 2012	15.78M
September 30, 2012	14.90M
June 30, 2012	14.56M
March 31, 2012	14.56M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

39.14M

Minimum

Jun 2020

70.06M

Maximum

Dec 2022

54.44M

Average

52.84M

Median

SG&A Expense (TTM) Benchmarks